Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RUBY: Treating Abnormal Postpartum Uterine Bleeding or Postpartum Hemorrhage With the Jada® System - A Post-Market Registry

NCT04995887 is registered in ClinicalTrials.gov with Alydia Health as lead sponsor.

NCT NCT04995887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RUBY: Treating Abnormal Postpartum Uterine Bleeding or Postpartum Hemorrhage With the Jada® System - A Post-Market Registry
Lead sponsor
Alydia Health
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
April 30, 2022
Enrollment
809 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage